The global rabies treatment market to grow at a CAGR of 4.91% during the period 2017-2021.
The report, Global Rabies Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The latest trend gaining momentum in the market is introduction of monoclonal antibodies. The spread of rabies infection can be prevented by the immediate administration of CCVs and RIGs. However, HRIG is not available developing countries such as India due to their high cost and transport complexities. Moreover, HRIG may transmit blood-borne diseases, as they are derived from human blood. Similarly, ERIG, derived from horse serum, causes various adverse effects. Extensive research and rigorous clinical trials to overcome this hurdle and meet the unmet demand for cost-effective biologics have led to the introduction of monoclonal antibodies to provide immediate immunity against rabies.
- Cadila Healthcare
Other prominent vendors
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Understanding rabies
PART 06: Pipeline analysis
PART 07: Market landscape
PART 08: Market segmentation by application
PART 09: Market segmentation by product type
PART 10: Market segmentation by route of administration
PART 11: Geographical segmentation
PART 12: Decision framework
PART 13: Drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
PART 16: Key vendor analysis
PART 17: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/zc8rcp/global_rabies